Darin K. Edwards - Concepedia

Author

Darin K. Edwards

Moderna Therapeutics (United States)ORCID

Also Known As

Darin Edwards, Darin K Edwards, Darin K. Edwards, Usachenko, Jodie L.

Publications

8.4K

Citations

H-Index

Concepts

All Affiliations

Moderna Therapeutics (United States)National Institute of Allergy and Infectious Diseases National Institutes of Health Washington University in St. Louis Brigham and Women's Hospital

About

Darin K. Edwards is an author at Moderna Therapeutics (United States) specializing in immunology, medicine, and vaccine development.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	26	3.6K
2	Immunology	24	26	3.6K
3	Cell Biology	2	2	261
4	Clinical Immunology	1	1	12
5	Autoimmunity	1	1	96

Darin K. Edwards

Publications

7.5K

Citations

H-Index

Page 1

	Year	Citations
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness Kizzmekia S. Corbett, Darin K. Edwards, Sarah R. Leist, Nature VaccinationPrototype Pathogen PreparednessVaccine DevelopmentImmunologyVirology	2020	1.6K
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates Kizzmekia S. Corbett, Barbara J. Flynn, Kathryn E. Foulds, New England Journal of Medicine	2020	1.1K
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 Spyros Chalkias, Charles Harper, Keith Vrbicky, New England Journal of Medicine	2022	638
mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants Anne P. Werner, Juan I. Moliva, Matthew Koch,	2021	479
Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis Angela Choi, Matthew Koch, Laurence Chu, Nature Medicine	2021	446
Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates Kizzmekia S. Corbett, Martha Nason, Britta Flach, Science VaccinationVaccinologyMrna-1273 VaccineViral ReplicationVaccine Development	2021	322
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron Matthew Gagné, Juan I. Moliva, Kathryn E. Foulds, Cell VaccinationVaccine DevelopmentVaccine ResearchHumoral ResponseImmunology	2022	224
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice Suzanne M. Scheaffer, Diana Lee, Bradley Whitener, Nature Medicine VaccinationVaccine DevelopmentVaccine TargetImmunologyVirology	2022	178
Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial Spyros Chalkias, Frank Eder, Brandon Essink, Nature Medicine	2022	143
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness Kizzmekia S. Corbett, Darin K. Edwards, Sarah R. Leist,	2020	142

Page 1